Moderna shares drop as patent ruling goes against the biotech company
The clinical stage biotechnology company has said its development of a vaccine for COVID-19 will not be affected.
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: BRIAN SNYDER/REUTERS)ByDONNA RACHEL EDMUNDS
